Zepp Health Operating Margin 2017-2025 | ZEPP
Current and historical operating margin for Zepp Health (ZEPP) over the last 10 years. The current operating profit margin for Zepp Health as of March 31, 2025 is -36.58%.
| Zepp Health Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.18B | $-0.05B | -27.47% |
| 2024-12-31 | $0.18B | $-0.05B | -26.23% |
| 2024-09-30 | $0.21B | $-0.04B | -18.45% |
| 2024-06-30 | $0.25B | $-0.02B | -9.72% |
| 2024-03-31 | $0.30B | $-0.02B | -8.05% |
| 2023-12-31 | $0.35B | $-0.03B | -8.52% |
| 2023-09-30 | $0.42B | $-0.04B | -9.40% |
| 2023-06-30 | $0.50B | $-0.05B | -9.96% |
| 2023-03-31 | $0.58B | $-0.06B | -9.91% |
| 2022-12-31 | $0.60B | $-0.06B | -10.00% |
| 2022-09-30 | $0.70B | $-0.04B | -5.97% |
| 2022-06-30 | $0.82B | $-0.02B | -2.57% |
| 2022-03-31 | $0.83B | $-0.01B | -1.45% |
| 2021-09-30 | $1.05B | $0.02B | 2.29% |
| 2021-06-30 | $1.13B | $0.03B | 2.30% |
| 2021-03-31 | $1.01B | $0.02B | 1.59% |
| 2020-12-31 | $0.99B | $0.03B | 2.74% |
| 2020-09-30 | $0.95B | $0.05B | 4.96% |
| 2020-06-30 | $0.88B | $0.07B | 7.50% |
| 2020-03-31 | $0.87B | $0.08B | 8.97% |
| 2019-12-31 | $0.84B | $0.09B | 10.42% |
| 2019-09-30 | $0.70B | $0.07B | 10.63% |
| 2019-06-30 | $0.59B | $0.06B | 10.32% |
| 2019-03-31 | $0.56B | $0.06B | 11.35% |
| 2018-12-31 | $0.53B | $0.05B | 9.83% |
| 2018-09-30 | $0.48B | $0.15B | 31.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.037B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.313B | 58.92 |
| Tempus AI (TEM) | United States | $11.516B | 0.00 |
| Doximity (DOCS) | United States | $11.474B | 53.12 |
| Hims & Hers Health (HIMS) | United States | $11.060B | 114.91 |
| IRhythm Technologies (IRTC) | United States | $4.939B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.905B | 61.02 |
| Hinge Health (HNGE) | United States | $3.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.815B | 10.12 |
| Phreesia (PHR) | United States | $1.695B | 0.00 |
| Schrodinger (SDGR) | United States | $1.512B | 0.00 |
| 10x Genomics (TXG) | United States | $1.444B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.405B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 65.09 |
| Omnicell (OMCL) | United States | $1.376B | 24.28 |
| Evolent Health (EVH) | United States | $1.310B | 111.60 |
| Claritev (CTEV) | United States | $0.716B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.452B | 0.00 |
| TruBridge (TBRG) | United States | $0.349B | 773.33 |
| Outset Medical (OM) | United States | $0.338B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.167B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.109B | 0.00 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| 111 (YI) | China | $0.060B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |